As the Omicron variant of COVID-19 started to wreak havoc around the world causing a steep rise in the number of cases, the authorities have been taken aback fearing another wave taking the lives of many as we saw in early 2021.
Thankfully, initial studies on the new variant indicate that Omicron is not as deadly as its predecessor, the Delta variant. It, however, is more contagious than the previous strains. So, the rapid increase in positivity rate has forced the global bodies to come up with a solution to this problem.
WHO periodically organizes consultations with an independent group of experts, the Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), to review the evidence and analyse the implications of emerging variants on the performance of COVID-19 vaccines.
The body comprising independent experts suggested the need of more studies and research to understand if the composition of the current COVID-19 vaccines may need to be changed to ensure that they provide higher protection against the Variants of Concern (VOCs), including Omicron or any other future strains.
Some experts have stressed on the need for COVID-19 vaccines to produce broader, stronger and lasting immune responses to eliminate the need for successive booster doses. They opined that a vaccination strategy that is based on repeated doses of the original vaccine composition is not sustainable or appropriate.
The WHO panel, however, did not recommend the need for an Omicron-specific vaccine at the moment. They said that this can only be considered once there is enough evidence and also requested the vaccine manufacturers to share data available to them.
Viruses keep on changing and newer variants with newer characteristics may appear in future. There are chances of more mutations coming up in future.
As many as 10 vaccine manufacturing companies around the world are currently working on bringing up vaccines for COVID-19. Moreover, a total of seven potential vaccine candidates that are still under development are being tested against the new variant. Some of these newer vaccines are expected to be released in the months to come.
Here is the list of vaccines that are under development –
UNICEF has explained that some of the above-mentioned candidates may be used as booster shots or independent vaccines against the virus.
Here is the list of already existing vaccines that are being tested against the new Omicron variant –
Furthermore, the Indian Council of Medical Research (ICMR) has also started to study the effectiveness of already existing COVID-19 vaccines – Covishield and Covaxin – against the Omicron variant.
Studies are under process to understand the effectiveness of existing vaccines and also to evaluate the need for any modification in the vaccine composition for better protection against the newer variants. It is important for us to know that even the existing vaccines offer good protection against severe illness and death due to COVID. while We should therefore continue to get vaccinated (if eligible), and keep ourselves safe from this highly contagious variant of COVID-19. State governments across India have already imposed multiple restrictions to contain the spread of the virus and its variants. Now, it is our responsibility to keep ourselves and our loved ones safe from the virus. So, keep following the social protocols and stay healthy!
The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
When India is troubled by a steep rise in the cases of the Omicron variant of COVID-19, the United States and some European countries are facing an all-new threat called “Delmicron”. Now, you would be filled with so many queries like if this is a new variant of Coronavirus? If this is going to trigger the third wave? If it is deadlier or milder than the Omicron variant?
First of all, there is no need to panic and we are here to answer all your queries.
Delmicron is not a new variant of Coronavirus, but as per the experts, it is the term used for the infections spreading together due to twin spikes of Delta and Omicron variants. The name has also been derived by combining the names of the previous two variants of COVID-19. The reason for coming up with this name was that both variants are being found all over the world.
Currently, the US and UK are the COVID-19 hotbeds across the globe. According to the data published by the Centers for Disease Control and Prevention (CDC), Omicron has already taken over the Delta variant with about 73 percent sequenced cases (by December 18). Just a week earlier, the Delta variant was dominating with a total of 87 percent caseload.
Even more shockingly, CDC has estimated that over 90 percent of the cases in portions of the Northwest, South, Southeast and Northeast are of the Omicron variant. These numbers clearly show that the US is battling both variants at the same time. The UK is also facing a similar situation with the number of cases rising rapidly.
The symptoms of the Delmicron are similar to Delta and Omicron variants of COVID-19. Please have a look at the most common symptoms reported by the patients:
The researchers have claimed that both, Omicron and Delta variants, are highly transmissible. The UK government scientists, however, have claimed that people who contract the Delta variant are more likely to fall sick with serious symptoms than those who get infected with the Omicron variant.
The Indian scientists are yet to figure out how the Omicron variant would behave in the localities where there is widespread exposure to the Delta variant. Some of them, however, think that the Omicron variant would not affect the Indian population as badly as the Delta strain of COVID-19.
Looking at the high transmissibility of the Omicron variant, some experts believe that even if a majority of people report mild symptoms, third wave can affect a larger population. The total number of hospitalisations can still be higher if we do not limit the spread of this virus. Are we on the brink of the third COVID-19 wave?
India has started to feel the heat of carelessly celebrating the holiday season of the New Year 2022. On Friday, 7th Jan 2022, India has reported 1,17,100 cases of COVID-19 infection which is way higher than a few weeks earlier when there were just about 5,000 cases being recorded in a day. It would not be wrong to say that we are heading towards yet another wave of COVID pandemic.
The governments of respective states have started to impose night curfews and close down schools and cinema halls, but all this would be futile if we as the citizen of India do not understand our responsibility and abide by the social protocols established by the government. All of us must avoid social gatherings, wear a mask whenever outside and maintain physical distancing at public places. Getting vaccinated is also one of our main responsibilities to protect ourselves and our country from the dreadful effects of COVID-19.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
The holiday season is just around the corner as we are about to wrap up the year 2021. It definitely was not as anyone would have expected it to be but together, we somehow managed to emerge victorious over the Delta variant of COVID-19 that had wreaked havoc around the world in mid-2021.
Well, we might have won a battle against COVID-19 but the war is far from over as the virus has struck back with a brand new variant named Omicron, and with winter celebrations and New Year in the offing, its spread is most likely to become rampant all across the world.
There, however, are still some ways that can help us in containing the spread of the Omicron variant despite it being more contagious than the Delta variant. Below, we have mentioned some expert advice on how to stay and keep your family members safe during the holiday season amid the Omicron crisis. Have a look:
Apart from avoiding huge gatherings, you should also maintain at least a six-feet distance from others when outdoors. Masks have not yet become optional accessories but continue to be an essential safety net in the war against COVID-19.
One must wear their mask properly so it covers their nose and mouth.
This is the first thing you need to do to save yourself from contracting this virus. While the scientists are yet to ascertain if Omicron is more severe than the Delta variant, experts have advised not to join any large gatherings and to prefer being outdoors instead of attending or throwing indoor events.
As people tend to travel a lot during the New Year festive season, the experts have advised people to be a little more flexible about the place they want to visit. Doing some research about the place you want to visit and finding out the active number of COVID-19 cases in the locality can help you in staying safe. Moreover, you can also find out the vaccination coverage in the particular region to better evaluate the risk of visiting there.
Gather with others who are up-to-date on their vaccines and who you can count on to not come if they have symptoms. Smaller gatherings can be lower risk than larger gatherings. Gatherings held outdoors are lower risk for spread than indoor gatherings. All this reduces your risk of spreading a virus.
Dr. M.G. Kartheeka, MBBS, MD
The Indian healthcare system has impressively covered a huge number of people in terms of COVID-19 vaccinations but still, there are a lot of people who are either yet to receive their second dose or have not got jabbed even once. So, the best possible way to prevent the Omicron infection is to get vaccinated on priority. There are speculations that the new variant may be able to cause breakthrough infection, but nothing is confirmed as of now. Furthermore, the initial studies prove that the Omicron virus can dodge immunity only to some extent. Hence, getting jabbed is the best defence mechanism we can opt for at the moment.
While travelling outstation, it is a good practice to keep some rapid test kits handy to determine if you have contracted the virus or not. Despite not being fully accurate, they can largely help in diagnosing the infection in the early days helping you to get early treatment as well as isolation.
Do not ignore any symptoms of illness- fever, sore/scratch throat, weakness, body ache etc. Isolate yourself, consult a doctor and do not meet other people till you are not sure of your disease. It is important for the safety of your loved ones.
Also Read: Is Covishield Effective Against Omicron?
COVID-19 was about to enter the endemic stage before the Omicron variant first appeared in South Africa and has spread to several countries since then. India itself has reported over 200 cases as of now, with Delhi and Maharashtra being the hub of the spread with 54 cases each. Hence, it is our responsibility to celebrate the upcoming holiday season cautiously and contain the spread of this variant before it becomes rampant. Virtual parties can be a safe and happy mode of celebration. Avoid any unnecessary travel, act responsibly and don’t forget to keep your masks on!
Also Read: Precautions to Take Against The Omicron Variant
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
We all have understood that COVID-19 is here to stay and we will have to make our peace with this fact. Similar to Influenza, some experts opine that SARS CoV-2 may also enter the endemic stage. What does this really mean and how is our behaviour significant at this time? Let’s find out.
The endemic stage stands for a time when a population learns to live with a particular virus. The region where the virus has entered the endemic stage may keep observing small flare-ups of the spread but those would not be big enough to spread beyond the boundaries of that particular region. Moreover, the spread also does not become as overwhelming as it was during the pandemic or epidemic stages.
Director of the National Institute of Allergy and Infectious Diseases and the Chief Medical Advisor to the US President, Dr Anthony Fauci believes that the world would start seeing a decline in the number of cases in the coming spring, while Moderna’s CEO, Stéphane Bancel claims that the pandemic would be over within next one year.
Some experts believe that the cases of COVID-19 are going to see a steady decline in the winter season
The only challenge in the way of the virus entering the endemic stage is ‘human behaviour’, claimed the experts. One of the biggest reasons behind the second wave of infection was the careless attitude of people around the world who believed that the worst was over. Expressing the same concern, CDC Director Dr Rochelle Walensky said, “We are battling with one another and not battling with the common foe, which is the virus itself.”
Director-General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus has also claimed that the pandemic is still far from over and it totally depends upon the countries to use the available tools effectively to decide when it finally comes to an end.
Optimism is totally justified, given people understand their responsibility. Experts have claimed that it is quite natural to be optimistic and believe that the pandemic would end in the next year, but it is important to understand that controlling it would require a global solution.
Learnings from past experiences of pandemics like that of Flu give us some idea of how this pandemic can proceed towards endemicity, but nothing can be assured at this point of time till further studies affirm this.
According to the experts, immunization has a major role to play when talking about COVID-19 cases. We need to encourage more and more people to get vaccinated.
Some experts have also claimed that an optional booster dose of vaccine may help the high-risk population from getting severe symptoms due to COVID infection. Challenges in the way of COVID-19 entering the endemic stage. Vaccination is the most effective way of containing the spread of the virus, vaccine hesitancy, especially among children, is the biggest roadblock in the way of the virus getting into the endemic stage.
The experts have advised people to get vaccinated on priority as this is the safest way possible to try and make a place COVID-19-free. With the belief that the virus is going to remain in circulation even after a year, we need to be alert to combat every situation.
Studies and research are still going on and no one can actually state what’s going to come next. The virus has surprised us in the part and there is no guarantee it would not do it again, so dropping the guard against the virus may not be a good idea. Social distancing, hand hygiene, respiratory etiquettes, wearing a mask and avoiding crowded places should remain the norms of conducting ourselves in future too.
Also Read: Omicron Variant: Risks & Safety Precautions
The health experts around the world are convinced that the COVID-19 pandemic is bound to enter the endemic stage sometime in the next year, but it is up to us how we conduct ourselves during the period to expedite the process.
Disclaimer: The information included at this site is for educational purposes only and is not intended to be a substitute for medical treatment by a healthcare professional. Because of unique individual needs, the reader should consult their physician to determine the appropriateness of the information for the reader’s situation
COVID-19 has been a pandemic everyone of us just wants to be over and forget these horrifying couple of years once and for all. It has not been an easy situation to handle for any of us ever since it first appeared in central China back in December 2019. It, however, has been even tougher for certain people who have a weaker immune system.
Many studies have proven that COVID-19 is even deadlier for those whose immune system isn’t up to the mark or are suffering from a condition that compromises their immune system.
It would not be wrong to say that people who are already suffering from Human Immunodeficiency Virus infection and Acquired Immune Deficiency Syndrome (HIV/AIDS) have been the most troubled lot amongst the people susceptible of getting severe symptoms and hospitalisation due to the respiratory infection.
Ever since the coronavirus started spreading across the globe, the healthcare community was worried that it was going to severely affect HIV patients and those with a compromised immune system.
The anticipation was not wrong as the weaker immune system of HIV patients might not have played a role in making them more prone to get infected but it most certainly increased the chances of a more severe case of COVID-19, once the virus was contracted.
Lauren K. Barbera, from the University of Colorado and her teammates, in a review article published in HIV Research and Clinical Practice, have claimed that the recent studies have proven that people with HIV (PWH) are at a bigger risk of suffering from a severe disease on contracting COVID-19, even if they have fairly controlled HIV infection.
The review paper submitted by Barbera and her colleagues had combined a total of 212 articles published on the subject from March 2020 to July 2021.
A real extensive study, conducted on over three million patients in South Africa, suggests that HIV patients have a two-fold bigger risk of COVID-19 death, irrespective of CD4 count or HIV viral load. Some other studies have also suggested similar outcomes for HIV patients.
In yet another shocking stat, people living with HIV, who are about 0.7 percent of the world’s population, accounted for about 0.5 to 1.5 percent of COVID-19 cases around the globe.
Discussed below are some facts giving a more clear picture of the correlation between COVID-19 and HIV. Have a look:
Fever, shortness of breath, cough and cold are some of the most common symptoms of COVID-19. Other symptoms may include muscle pain, loss of smell and taste and headaches.
The authors of the study, conducted on 286 people with HIV, have found that they noticed similar symptoms in them too. People with HIV should consult their doctor even if they notice the slightest discomfort or any of the above-mentioned symptoms.
The review also claimed that a lot of studies and case reports suggest that people suffering from HIV, who contract COVID-19 infection, are more susceptible to be severely ill or get admitted to ICU than the people who do not have HIV.
The reviewers also claimed that the mortality rate due to COVID-19 is also higher among HIV patients. The study quoted in the review to support the mortality rate is based on a study conducted in the United Kingdom that proved it to be true. The number of deaths reported in the study, however, was relatively low.
As we all know, social distancing, quarantining and self-isolation due to COVID-19 has had a huge impact on the mental health of people in the recent past. According to Barbara and her teammates, the studies have found the impact to be even bigger on the minds of HIV patients.
One of the studies in the review submitted by the team of the University of Colorado proved that people suffering from HIV were more concerned about their physical health, mental health, accommodations and finances during the pandemic.
The researchers also pointed out that telemedicine played a big role in preventing these mental issues turn into something serious due to the privacy and flexibility it offers but the HIV patients had to overcome the barriers of socioeconomic status, digital literacy and reimbursement issues.
As expected, HIV patients had to be even more cautious during the COVID-19 pandemic because of their compromised immune systems and should continue their treatment and follow-ups for HIV. There, however, was a silver lining that they also had to take the same precautions to avoid contracting the virus as a non-HIV infected l person.
As we are advancing towards endemicity in India, we should not lower our guard against the virus. We all should unite to follow all the precautionary measures like social distancing, wearing a mask, frequently washing our hands, and getting vaccinated as soon as possible to finally kick this virus out of our country.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
“Breakthrough infection” is a new term that you may have heard recently. It stands for those people who are fully vaccinated for at least two weeks and then contract COVID-19 infection. It is very much similar to unvaccinated people who get infected with the virus but there are some differences in the symptoms and intensity of the infection.
According to a study conducted on the symptoms of the breakthrough infection, it presents itself with signs like –
Some of these symptoms are exactly the same that unvaccinated people experience when they contract COVID-19. The common symptoms are –
Notably, there are a couple of more symptoms that usually vaccinated people do not experience. They are –
These two are the most common COVID-19 symptoms but vaccinated people are way less likely to experience these problems. According to a study, people who suffer from breakthrough infection are 58 percent less likely to experience heightened body temperature as compared to the people who did not get their jabs.
A few studies have also proven that people who have already taken both their shots of COVID-19 are less likely to be hospitalised than people who have not taken the vaccine yet.
The other difference is that vaccinated people are less likely to experience any symptoms in the initial stages of the infection and also may not develop long COVID.
As per the experts, the reason behind vaccinated people developing milder symptoms could be the vaccines. Even if these vaccines are unable to block the infection entirely, they seem to ensure that the infected person has fewer virus particles in his/her body.
This belief is yet to be proven with concrete studies but the recent cases suggest the same story.
Read More: All About The Omicron Covid Variant
According to a study conducted in the United Kingdom, 0.2 percent of the population, which means one in every 500 people, suffers from breakthrough infection after being fully vaccinated. The researchers, however, confirmed that the risk is not the same for everyone. They highlighted four things that may be contributing to your shield against COVID-19. Have a look –
The most important and the first aspect should be the type of vaccine you have taken and the relative risk reduction it offers. Relative risk reduction stands for a measurement of how less likely you become to contract the infection as compared to an unvaccinated person.
The relative risk reduction doesn’t completely assure you that the effects of the vaccine are going to last forever. Over the past few weeks, the debate over the third dose of the vaccines has intensified only because the scientists and researchers believe that the efficacy of the vaccines is surely going to wane off as time passes.
Therefore, if you have had taken the second dose of the vaccine more than six months ago, you might be more prone to catch the breakthrough infection.
A variant of the virus sure does play a crucial role in defining your risk of contracting the breakthrough infection of COVID-19. Most of the studies that we currently have read had been conducted on the original form of the Coronavirus that hit the world back in December 2019.
The efficacy of most of the available vaccines drops when they are dealing with the Alpha variant of Coronavirus and when it comes to the delta variant, the efficacy drops even further. As the virus is expected to keep mutating in future too, the efficacy of the vaccines may drop even further, leaving us more vulnerable to breakthrough infection.
Also Read: Omicron vs Other Variants
The above-mentioned factors are based on a general study on a population, irrespective of the overall health of a particular person. It means that your level of protection against breakthrough infection also depends upon your overall health, how strong your immunity is and the other person-specific factors.
You may be more vulnerable to the breakthrough infection because you work in the healthcare sector where you stay more exposed to the virus or your age is over 50 years or you already suffer from a chronic ailment that has compromised your immune system, etc. These may be the contributing factors to your vulnerability.
Notably, all the countries had first vaccinated the people who were most vulnerable to the infection, which means that most of them took their second dose about 6-7 months back. Hence, their immunity against COVID-19 may have waned off by now putting them at risk again.
Despite the above-discussed risk factors, vaccines surely are our biggest weapon against COVID-19 disease. Even if they are unable to give 100 percent protection against breakthrough infection, they surely are keeping the chances of severe illness and hospitalisation at the lowest.
There are plenty of countries that are planning to start administering the third dose of the vaccine to provide sturdier protection against COVID-19. Initially, they are planning to administer the dose to the vulnerable groups and then move on to the entire population. This may become a norm in the months to come in every country.
The vaccines might be failing to prevent breakthrough infection in a few cases but they should not be interpreted in any way that these are not effective. The only way we can defeat COVID-19 is by getting vaccinated as soon as possible. When there would be fewer people getting infected, the virus would eventually disappear. Moreover, we should also ensure to keep all the risk enhancing factors in mind to prevent the spread of the virus.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
India is seeing a sharp rise in the number of people being diagnosed with heart-related conditions and once again, the reason somewhere seems to be COVID-19. Yes, doctors in many cities across the country have noticed that the people who recovered from severe COVID-19 have been encountering heart issues like heart attacks, chest pains, heart failure, low pump capacity, arrhythmia, blood clotting, heart-swelling, etc.
These issues have majorly occurred within three months of their recovery from COVID-19.
As we all know, COVID-19 is a disease that infects the lungs but what many people did not know is that it also impacts the other body parts, including but not limited to the cardiac system.
While you undergo treatment for COVID-19, your immune system also tries to fight the virus and both these things lead to a high level of inflammation inside the body. This eventually leads to complications outside the lungs too.
This is the reason why people who never had any cardiac issues before contracting COVID-19 have reported cardiac issues after recovering from the infection.
There are plenty of complications a COVID-19 patient may experience after recovering successfully from the disease. Generally, these complications arise within three months of the recovery.
As per the experts, this problem has been mainly found among young and middle-aged adults and elderly patients. They experienced shortness of breath, chest pain and palpitations. Explaining the same, the experts claimed that these complications could be the result of heart-related problems but they can also be the result of other factors, like the result of being extremely ill for a long time, staying inactive for a long period of time, spending weeks in bed to recover from a disease, etc.
The experts have also suggested that people who already had heart-related problems before being diagnosed with COVID-19 must take good care of themselves and take all the precautions, medications and follow-ups with the doctor. This may help them in preventing any major complications.
Furthermore, the experts have figured out that people with diabetes, high cholesterol and chronic kidney disease are more prone to suffering from cardiac problems after recovering from COVID-19.
The doctors also claimed that such cases have become more prevalent ever since the second wave of COVID-19, as there were not many cases noticed during the first wave. Moreover, the doctors have noticed extended use of steroids during the second wave which could be a reason behind these problems.
Experts suggest that people who have recovered from COVID-19 must ensure that they go for regular cardiac screening, and the frequency should be at least once every six months. They should also stick to a healthy diet and follow a regime of physical activities.
Moreover, they also should keep taking the medications suggested by their doctor.
Mentioned below are the precautions a cardiac patient should take post-COVID-recovery under the supervision of a qualified registered physician or cardiologist:
The cases of heart-related complications after COVID-recovery have gone significantly up during the past few months. It is really important for everyone to take good care of themselves even after recovering from the disease. Regular checkups and other precautions may help you keep yourself safe. With the third wave spreading its wings across the country, we should be even more cautious to reduce the effects of the deadly disease to the minimum levels.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
